| 摘要 |
<p>The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of Screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumours, e. g. prostate or breast cancer tumours and tumour metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.</p> |
